PBMs are Clear as Mud: The Value of a Fee-Based, Transparent Model
Transparency in the drug supply chain is desperately needed to deliver consumers the lowest cost and highest value prescription drugs.
Tag: price transparency
ACHP Letter to Acting FDA Commissioner on the Accelerated Approval of Drugs and Biologics
ACHP sent a letter to FDA’s Acting Commissioner, Sara Brenner, with comments on the Expedited Program for Serious Conditions.
ACHP Letter to Congress on Year-End Priorities
ACHP sent a letter encouraging Congress to act on key health care policies before the end of the 118th Congress.
Sen. Wyden, Rep. Moore Recognized with ACHP’s 2023 Legislative Champion Award
ACHP presented its 2023 Legislative Champion awards for visionary leadership to expand access to high-quality health coverage and care to Senator Ron Wyden (D-OR) and Congressman Blake Moore (R-UT).
ACHP Letter to CMS on Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems
ACHP sent a comment letter to CMS on the Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs proposed rule.
